Administrative Court Error Complicates Infarmed Vaccine Data Transparency

By João L. Carapinha

February 23, 2026

Court Clerical Error Threatens Infarmed Vaccine Data Transparency

Infarmed vaccine data transparency hangs in the balance due to a clerical error by the Lisbon Administrative Court’s secretariat, which sent a January 16 dispatch from Judge Ana de Campos to PÁGINA UM’s former lawyer. This misstep interpreted the outlet’s silence on Infarmed’s compliance with a data release order as implicit confirmation, potentially allowing Infarmed to evade full disclosure of COVID-19 vaccine pharmacovigilance data. Despite PÁGINA UM’s prompt reply, the judge may deem the matter moot, extending litigation and highlighting delays in accessing adverse reaction reports from vaccines and Remdesivir.

Gaps in Released Vaccine Data

Partial pharmacovigilance data from Infarmed, released in August 2024 and covering only December 2020 to December 2021, reveals critical omissions like causality grading, dose numbers, batch details, age, municipality, and notifier profession. Of 27,220 adverse reactions, 7,110 were serious, including 104 deaths—such as an 80+ year-old woman dying two minutes after Pfizer vaccination and a man from pulmonary thromboembolism 15 minutes post-dose. Under-25s saw 513 serious reactions (225 without follow-up), plus nine deaths in the 25-49 group. Broader Portal RAM data to August 2024 showed 19,224 of 45,337 entries (42.4%) with “unknown” outcomes, including myocarditis/pericarditis, anaphylaxis, embolisms, Guillain-Barré, strokes, thromboses, and infarctions.

PÁGINA UM’s December 6, 2021, request for Remdesivir and COVID-19 vaccine data was denied by Infarmed under Rui Santos Ivo, leading to the Commission on Access to Administrative Documents. On March 16, 2022, it ordered anonymized release, rejecting refusals. Infarmed’s non-compliance triggered summons, a March 2023 overturned ruling, and a July 11, 2024, Tribunal Central Administrativo do Sul order for full data. Infarmed’s truncated response prompted PÁGINA UM’s July 2024 fine request (€200 minimum daily on Ivo).

Reference url

Recent Posts

Null Link Confirmed: Prenatal Acetaminophen Autism Risk Study in Denmark

By HEOR Staff Writer

April 17, 2026

A major nationwide Danish cohort study has found no link between maternal acetaminophen use during pregnancy and autism in children. The new evidence on prenatal acetaminophen autism risk should reassure clinicians and expectant mothers, as both population-wide and sibling-controlled analyses sho...
Amyloid-Beta Treatment Impact: Limited Clinical Benefits and Increased Risks in Early Alzheimer’s...

By HEOR Staff Writer

Amyloid-Beta Treatment Impact on people with early Alzheimer’s disease is minimal, according to a major new Cochrane review. The analysis of 17 randomized controlled trials involving more than 20,000 participants found that amyloid-beta-targeting monoclonal antibodies deliver only trivial improve...
HIV Prevention Partnerships: Expanding Access to Lenacapavir for Global Impact

By João L. Carapinha

HIV Prevention Partnerships between PEPFAR, The Global Fund, and Gilead Sciences are accelerating access to twice-yearly injectable lenacapavir for HIV pre-exposure prophylaxis (PrEP) in high-burden countries. Unprecedented Speed to Sub-Saharan Africa This additional i...